Medical News

RSS

QPharma launches Compliance Advantage solution

QPharma, Inc. has announced the launch of its Compliance Advantage solution, a set of tools and methodologies to streamline compliance and validation activities for life science companies implementing enterprise application systems.

21 Sep 2012

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.

21 Sep 2012

Itrim programme effectively reduces weight among obese people

Anyone who wants to lose weight has a wide variety of diets to choose from, but knowledge of what works is often poor. Researchers at Karolinska Institutet and Uppsala University have now evaluated a Swedish commercial weight loss programme called Itrim, and found it to be effective. After one year, participants had lost 11 kg on average.

21 Sep 2012

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

The Affordable Medicines Facility-malaria (AMFm) -- an innovative financing mechanism that subsidizes the cost of artemisinin-based combination therapies (ACTs) in order to expand access to the most effective treatment for malaria -- "brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011" and "also increased access to the top malaria medicines by 26 to 52 percent in six countries."

21 Sep 2012

Availity earns healthcare network accreditation from EHNAC

Health information network Availity today announced it has achieved renewed accreditation with the Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body that recognizes excellence in health data processing and transactions.

21 Sep 2012

Medivir’s simeprevir and TMC647055 to enter phase IIa combination trial for HCV genotype-1

Medivir AB, announced today that simeprevir (TMC435) and TMC647055, a non-nucleoside inhibitor (NNI) will enter a phase IIa interferon free combination trial.

21 Sep 2012

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced it has received European CE Mark approval of its Eon family of neurostimulators for patients with intractable chronic migraine. Unveiled at the European Headache and Migraine Trust International Congress in London, this approval includes the Eon Mini neurostimulator, which is the world's smallest rechargeable neurostimulator with the longest-lasting battery in its class, and the Eon and EonC neurostimulators.

21 Sep 2012

Newly formed emotional memories can be erased from the human brain

Newly formed emotional memories can be erased from the human brain. This is shown by researchers from Uppsala University in a new study now being published by the academic journal Science. The findings may represent a breakthrough in research on memory and fear.

21 Sep 2012

Positive results from Galleon GAL-021 second Phase I study on respiratory depression

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing control disorders, today announced that results from a second Phase I clinical study of its investigational drug GAL-021 confirmed previous findings that the drug has dose-dependent effects on respiration.

21 Sep 2012

Research to gauge effectiveness of street-crossing training program in impaired people

An Indiana University assistant professor and low-vision optometrist working to advance pedestrian safety has been awarded more than $1.9 million by the National Institutes of Health to evaluate street-crossing decision-making performance in pedestrians who are elderly, visually impaired or blind.

21 Sep 2012

Hypertonic solution effective in reducing inflammation

Research carried out at The University of Manchester has found further evidence that a simple solution, which is already used in IV drips, is an effective treatment for reducing inflammation.

From The University of Manchester 21 Sep 2012

Systems biologist to pursue research into next-generation genome sequencing technology

Systems biologist Edward Marcotte has received a $2.5 million grant from the National Institutes of Health to pursue cutting-edge research in the area of genome sequencing technology.

21 Sep 2012

Researchers use nanoparticles to deliver drugs to mitochondria within cells

Nanoparticles have shown great promise in the targeted delivery of drugs to cells, but researchers at the University of Georgia have refined the drug delivery process further by using nanoparticles to deliver drugs to a specific organelle within cells.

21 Sep 2012

First Edition: September 20, 2012

Today's headlines include reports that the health law's penalty for not obtaining health insurance could hit as many as 6 million people.

21 Sep 2012

Titan Spine receives U.S. patent for competitive interbody devices

Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has been awarded patent #US 8,262,737 B2 by the United States Patent Office that protects the Company against competitive interbody devices with a roughened surface topography, anti-expulsion edges, and access to a hollow center.

21 Sep 2012

FDA data collection and analysis about arsenic levels in rice

As part of an ongoing and proactive effort to monitor food safety and address contaminants in food, the U.S. Food and Drug Administration today released preliminary data on arsenic levels in certain rice and rice products. The data are part of a larger FDA data collection and analysis about arsenic levels in rice and is based on the first set of approximately 200 samples of rice and rice products collected in the U.S. marketplace.

21 Sep 2012

Sagard Capital acquires IntegraMed

Sagard Capital Partners, L.P. and IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced the completion of Sagard Capital's acquisition of IntegraMed for $14.05 per share in cash, representing a total equity purchase price of approximately $169.5 million.

21 Sep 2012

MiR-34a plays a key role in obesity

Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice.

21 Sep 2012

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.

21 Sep 2012

Study finds nearly 50% decline in child mortality in Niger over the last decade

A study by researchers at the Johns Hopkins Bloomberg School of Public Health and the Niger Countdown Case Study Working Group found that child mortality in Niger-one of the world's poorest countries-declined nearly 50 percent over the last decade.

21 Sep 2012

Medical News

QPharma launches Compliance Advantage solution

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Itrim programme effectively reduces weight among obese people

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

Availity earns healthcare network accreditation from EHNAC

Medivir’s simeprevir and TMC647055 to enter phase IIa combination trial for HCV genotype-1

St. Jude Medical’s Eon family of neurostimulators receives European CE Mark approval

Newly formed emotional memories can be erased from the human brain

Positive results from Galleon GAL-021 second Phase I study on respiratory depression

Research to gauge effectiveness of street-crossing training program in impaired people

Hypertonic solution effective in reducing inflammation

Systems biologist to pursue research into next-generation genome sequencing technology

Researchers use nanoparticles to deliver drugs to mitochondria within cells

First Edition: September 20, 2012

Titan Spine receives U.S. patent for competitive interbody devices

FDA data collection and analysis about arsenic levels in rice

Sagard Capital acquires IntegraMed

MiR-34a plays a key role in obesity

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Study finds nearly 50% decline in child mortality in Niger over the last decade

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News